P&S Intelligence

The global age-related macular degeneration market was valued at $5,335.7 million in 2015, and it is expected to grow at a CAGR of 7.6% during 2016 - 2022.

The European Union point-of-care ultrasound device market is forecasted to generate $230.9 million revenue by 2024, progressing at a CAGR of 6.1% during the forecast period.

The global female fertility and pregnancy rapid test market is expected to grow at a CAGR of 4.5% during the period 2016 - 2022.

The global computed tomography market was valued at $4,894.3 million in 2015, and it is expected to grow at a CAGR of 5.0% during 2016-2022.

The global muscle relaxant drugs market is expected to grow with a CAGR of 5.5% during 2015 - 2020.

Dermatology drugs market is expected to reach $34.5 billion by 2023, according to P&S Intelligence.

Surgical simulation market is forecasted to generate revenue of $608.3 million by 2023, according to P&S Intelligence.

The global biopharmaceuticals market was valued at $ 160,440.4 million in 2014, and it is expected to grow with a CAGR of 9.6% during the period 2015 - 2020.

Biosimilars market is expected to generate $26.7 billion revenue by 2024, advancing at a CAGR of 29.6% during the forecast period, according to P&S Intelligence.

The human insulin (HI) market size is predicted to reach $70.6 billion by 2023, according to P&S Intelligence.